Scientists from the Max Delbrück Center discovered a potential new biomarker for Alzheimer’s

The Arl8b protein provides new insights into the mechanisms underlying Alzheimer’s disease. It also has the potential to function as a diagnostic marker. The scientists behind this discovery, a team led by Erich Wanker from the Max Delbrück Center,…

2 Min
More

AI-Supported Telemedicine Platform Aims to Improve the Health of Patients After Myocardial Infarction and Prevent Reinfarctions

A New Clinical Study in Europe Examines the Applicability and Effectiveness of the New TIMELY Platform for Telemedical Secondary Prevention

3 Min
More

Free qualification program for medtech startups

For founders with innovative product ideas in the areas of Medical Devices and In Vitro Diagnostics

 

1 Min
More

Special Topic | Well-trained professionals in the healthcare industry – The metropolitan region has a lot to offer

Software development, production, regulatory affairs, laboratory activities – the list of skills required by companies and research institutions is long. Where can companies and research institutions find freshly trained specialists for their…

19 Min
More

Max Delbrück Center scientists contribute to study that created the most comprehensive cell atlas of the human heart which include the cells from which the heartbeat originates

British and German scientists created the most comprehensive cell atlas of the human heart. As reported in the journal “Nature”, it is the first to include the cells from which the heartbeat originates. Among other things, this data will provide a…

3 Min
More

In portrait | Ariceum - Targeting and eliminating cancer cells

The Berlin-based company Ariceum Therapeutics is focusing on radiopharmaceuticals in its fight against difficult-to-treat cancers. It is planned that corresponding products will be brought into registration or approved in 2028. Ariceum is well on the…

5 Min
More

Save the Date - RegMed Forum 2023 | Advancing Sustainable and Inclusive Therapies: Establishing a Hub for Advanced Therapies in Berlin

23.11.23 | BCRT (BIH Center for Regenerative Therapies), Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Föhrer Str. 15, DE-13353 Berlin 09:00 a.m. – 03:00 p.m.

1 Min
More

Ten million euros for improved treatment of multiple sclerosis - Charité heads public-private partnership aimed at developing a diagnostic platform

Multiple sclerosis (MS) can take many different forms, which is why it is sometimes called “the disease of a thousand faces.” MS is also complex and difficult to treat. Now, an international consortium headed by Charité – Universitätsmedizin Berlin…

4 Min
More

IGES acquires majority stake in Synergus RWE – a European Medtech market access specialist

Continuation of its European growth course – Expansion of services for manufacturers of medical devices - Integration of the use of Scandinavian medical registries

2 Min
More

Scientists from BIH and Max Delbrück Center discover that T cells of the immune system are especially sensitive to genetic disturbances within their mitochondrial power plants

Some T cells of the immune system are especially sensitive to genetic disturbances within their mitochondrial power plants. Scientists from BIH and Max Delbrück Center have now published their findings in the journal “Nature Genetics”.

2 Min
More
Show more items